Insulin secretion predicts the response to therapy with exenatide plus pioglitazone, but not to basal/bolus insulin in poorly controlled T2DM patients: Results from the Qatar study
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Ralph A. DeFronzo |
| Publication date | December 11, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |